A detailed history of Raymond James & Associates transactions in Perkinelmer Inc stock. As of the latest transaction made, Raymond James & Associates holds 12,732 shares of PKI stock, worth $1.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,732
Previous 10,771 18.21%
Holding current value
$1.54 Million
Previous $1.3 Million 18.19%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
N/A
1,961 Added 18.21%
12,732 $1.54 Million
Q2 2024

Jul 19, 2024

BUY
N/A
2,957 Added 37.84%
10,771 $1.3 Million
Q1 2024

Apr 22, 2024

SELL
N/A
-138 Reduced 1.74%
7,814 $945,000
Q4 2023

Jan 16, 2024

SELL
N/A
-20 Reduced 0.25%
7,952 $962,000
Q3 2023

Oct 24, 2023

SELL
$115.88 - $122.81 $9,154 - $9,701
-79 Reduced 0.98%
7,972 $964,000
Q2 2023

Jul 25, 2023

BUY
$0.0 - $137.11 $0 - $91,863
670 Added 9.08%
8,051 $0
Q1 2023

Apr 14, 2023

SELL
$120.16 - $144.38 $142,149 - $170,801
-1,183 Reduced 13.81%
7,381 $983,000
Q4 2022

Feb 08, 2023

BUY
$119.0 - $147.98 $114,359 - $142,208
961 Added 12.64%
8,564 $1.2 Million
Q3 2022

Oct 25, 2022

SELL
$118.07 - $160.96 $8,737 - $11,911
-74 Reduced 0.96%
7,603 $915,000
Q2 2022

Aug 12, 2022

SELL
$134.91 - $172.49 $808,245 - $1.03 Million
-5,991 Reduced 43.83%
7,677 $1.09 Million
Q1 2022

May 11, 2022

BUY
$162.31 - $192.2 $394,575 - $467,238
2,431 Added 21.63%
13,668 $2.39 Million
Q4 2021

Feb 08, 2022

SELL
$166.66 - $201.06 $3.64 Million - $4.39 Million
-21,827 Reduced 66.01%
11,237 $2.26 Million
Q3 2021

Nov 02, 2021

SELL
$151.98 - $190.5 $590,746 - $740,473
-3,887 Reduced 10.52%
33,064 $5.73 Million
Q2 2021

Aug 11, 2021

SELL
$127.81 - $155.84 $1.92 Million - $2.34 Million
-15,016 Reduced 28.9%
36,951 $5.71 Million
Q1 2021

May 14, 2021

SELL
$120.35 - $160.53 $909,966 - $1.21 Million
-7,561 Reduced 12.7%
51,967 $6.67 Million
Q4 2020

Feb 12, 2021

BUY
$122.05 - $147.91 $4.14 Million - $5.02 Million
33,912 Added 132.39%
59,528 $8.54 Million
Q3 2020

Nov 04, 2020

BUY
$97.09 - $125.51 $1.52 Million - $1.97 Million
15,660 Added 157.29%
25,616 $3.22 Million
Q2 2020

Jul 28, 2020

BUY
$70.83 - $105.31 $20,399 - $30,329
288 Added 2.98%
9,956 $977,000
Q1 2020

Apr 21, 2020

SELL
$66.71 - $101.73 $407,598 - $621,570
-6,110 Reduced 38.72%
9,668 $728,000
Q4 2019

Feb 12, 2020

BUY
$79.1 - $97.45 $236,825 - $291,765
2,994 Added 23.42%
15,778 $1.53 Million
Q3 2019

Nov 07, 2019

SELL
$79.44 - $98.79 $754,123 - $937,813
-9,493 Reduced 42.61%
12,784 $1.09 Million
Q2 2019

Aug 06, 2019

BUY
$84.06 - $101.12 $20,678 - $24,875
246 Added 1.12%
22,277 $2.15 Million
Q1 2019

May 06, 2019

BUY
$72.79 - $97.5 $519,793 - $696,247
7,141 Added 47.96%
22,031 $2.12 Million
Q4 2018

Feb 11, 2019

BUY
$71.87 - $97.02 $199,942 - $269,909
2,782 Added 22.98%
14,890 $1.17 Million
Q3 2018

Nov 14, 2018

BUY
$72.59 - $97.27 $438,661 - $587,802
6,043 Added 99.64%
12,108 $1.18 Million
Q2 2018

Aug 14, 2018

BUY
$72.1 - $79.39 $211,252 - $232,612
2,930 Added 93.46%
6,065 $444,000
Q1 2018

May 14, 2018

SELL
$72.06 - $82.75 $44,605 - $51,222
-619 Reduced 16.49%
3,135 $237,000
Q4 2017

Feb 14, 2018

BUY
$69.36 - $73.84 $260,377 - $277,195
3,754
3,754 $274,000

Others Institutions Holding PKI

About PERKINELMER INC


  • Ticker PKI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 126,224,000
  • Market Cap $15.3B
  • Description
  • PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...
More about PKI
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.